Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Weekend Report: Commodities, Semis And Biotech

Published 08/20/2014, 07:08 AM
Updated 07/09/2023, 06:31 AM

Portions of the market bounced back strongly last week, led by technology. Bonds also had a strong week. Commodities continued to struggle, with Gold and Silver continuing to trend sideways to lower. I did a short article on corn earlier in the week and thought it looked like an interesting trade to the long side. The grains are still technically in a Stage 4 downtrend though.

Commodities are definitely in a do or die situation now as if they continue much lower from here the entire complex will be back in a Stage 4. If that transition occurs maybe the broad markets will continue to head higher. Semiconductors still look strong so they might be a good sector to look at for market leadership. Biotech is also looking like it wants to resume a Stage 2 uptrend. Many biotech stocks transitioned back into Stage 1 or 2 last week. Checkout the chart of iShares Nasdaq Biotech (NASDAQ:IBB) below and notice it has formed a potential cup and handle continuation pattern higher. It is also once again outperforming the S&P 500.

iShares Nasdaq Biotech

Portions of the market bounced back strongly last week, led by technology. Bonds also had a strong week. Commodities continued to struggle, with Gold and Silver continuing to trend sideways to lower. I did a short article on corn earlier in the week and thought it looked like an interesting trade to the long side. The grains are still technically in a Stage 4 downtrend though.

Commodities are definitely in a do or die situation now as if they continue much lower from here the entire complex will be back in a Stage 4. If that transition occurs maybe the broad markets will continue to head higher. Semiconductors still look strong so they might be a good sector to look at for market leadership. Biotech is also looking like it wants to resume a Stage 2 uptrend. Many biotech stocks transitioned back into Stage 1 or 2 last week. Checkout the chart of IBB below and notice it has formed a potential cup and handle continuation pattern higher. It is also once again outperforming the S&P 500.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.